THERE was double delight for a Hartlepool company when it lifted two crowns at an awards evening.
Hart Biologicals, based on the Queen’s Meadow Business Park in town, won the export award at the Bionow competition.
And one of it’s staff Keighley Campbell was chosen as the most promising technologist at the awards night held at the Baltic in Gateshead.
It prompted Hart Biologicals’ managing director Alby Pattison to comment: “It was a good night all round.”
The company is a specialist firm which deals with blood testing - both in hospital and at the scene of emergencies.
Keighley was nominated for the award by Mr Pattison, who first set up the company in 2002. The awards were held to “highlight the strength and depth of the cluster and the diversity of the companies within the sector”.
Keighley, 26, who works as a research and development manager for Hart Biologicals, has been with the firm for four years.
She as impressed on projects including one called the ultrasense range of coagulation reagents which relates to testing in hospital, such as on a patient where a diagnostic test was needed to assess any defects in their blood coagulation.
Keighley has also worked on rotem platelet projects. These can be used where someone is involved in an accident and medical experts need to assess their blood straight away.
Hart Biologicals manufactures reagents which are used to investigate the blood clotting function in patients taking blood thinning drugs such as warfarin, patients bleeding acutely during or after surgery or trauma, and those with blood coagulation disorders.
Last Autumn, the Mail revealed that Hart Biologicals was investing £1m in new equipment and facilities partly to link in with a new commercial contract in Germany.